Breaking News

Bayer, Covance Enter Strategic Partnership

Will leverage Covance's clinical development experience and services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bayer HealthCare has entered a long-term strategic partnership with Covance for clinical drug development, including R&D services related to Phase II to IV clinical trials and central lab services. Bayer plans to leverage Covance’s range of experience and services to enhance operational delivery, efficiency and quality, while also delivering financial benefits to both companies. Kemal Malik, executive committee member and head of global development at Bayer HealthCare, said, “This agr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters